ASX:RVA - REVA Medical Stock Price, News, & Analysis

Sign in or create an account to add this stock to your watchlist.
Previous CloseA$0.17
Today's RangeA$0.17 - A$0.17
52-Week RangeA$0.12 - A$0.38
VolumeN/A
Average Volume37,292 shs
Market Capitalization$70.56 million
P/E RatioN/A
Dividend YieldN/A
BetaN/A
REVA Medical, Inc., a medical device company, focuses on the development and commercialization of polymer-based bioresorbable products for vascular applications. The company offers Fantom Encore, a bioresorbable vascular scaffold for the treatment of coronary artery disease; and MOTIV bioresorbable vascular scaffold for the treatment of below-the-knee peripheral artery disease. It sells Fantom Encore in Germany, Switzerland, Austria, the Netherlands, Belgium, Luxembourg, Italy, and Turkey. The company was formerly known as MD3, Inc. and changed its name to REVA Medical, Inc. in March 2002. REVA Medical, Inc. was founded in 1998 and is headquartered in San Diego, California.

Receive RVA News and Ratings via Email

Sign-up to receive the latest news and ratings for RVA and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Industry Medical Devices
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone+1-858-9663000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$265,000.00
Book ValueA($0.18) per share

Profitability

Miscellaneous

EmployeesN/A
Market Cap$70.56 million
Next Earnings DateN/A
OptionableNot Optionable

REVA Medical (ASX:RVA) Frequently Asked Questions

What is REVA Medical's stock symbol?

REVA Medical trades on the ASX under the ticker symbol "RVA."

Has REVA Medical been receiving favorable news coverage?

News coverage about RVA stock has trended positive recently, according to InfoTrie Sentiment. The research group identifies negative and positive news coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of negative five to five, with scores closest to five being the most favorable. REVA Medical earned a news impact score of 2.3 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 10.0 out of 10, indicating that recent news coverage is extremely likely to have an effect on the company's share price in the near term.

Who are some of REVA Medical's key competitors?

Who are REVA Medical's key executives?

REVA Medical's management team includes the folowing people:
  • Ms. Regina E. Groves, CEO & Director (Age 61)
  • Mr. Robert B. Stockman, Co-Founder & Director (Age 65)
  • Mr. Jeffrey A. Anderson, Sr. VP of Clinical & Regulatory Affairs (Age 52)
  • Ms. Leigh F. Elkolli, CFO, Principal Accounting Officer, Corp. Sec. & Corp. Controller (Age 47)
  • Ms. Jessica Earley, VP of Operations & Product Devel.

How big of a company is REVA Medical?

REVA Medical has a market capitalization of $0.00 and generates $265,000.00 in revenue each year.

What is REVA Medical's official website?

The official website for REVA Medical is http://www.teamreva.com/.

How can I contact REVA Medical?

REVA Medical's mailing address is 5751 Copley Dr, SAN DIEGO, CA 92111-7911, United States. The company can be reached via phone at +1-858-9663000.


MarketBeat Community Rating for REVA Medical (ASX RVA)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  29 (Vote Outperform)
Underperform Votes:  30 (Vote Underperform)
Total Votes:  59
MarketBeat's community ratings are surveys of what our community members think about REVA Medical and other stocks. Vote "Outperform" if you believe RVA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe RVA will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 5/25/2019 by MarketBeat.com Staff

Featured Article: Bid-Ask Spread

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel